Add Yahoo as a preferred source to see more of our stories on Google. Covishield was developed by the British-Swedish company in collaboration with Oxford University, UK, and produced by the Serum ...
ZURICH (Reuters) - U.S. regulators have recommended pausing the use of Johnson & Johnson's COVID-19 vaccine as they investigate rare blood clotting in six women, including one who died. J&J also said ...
Experts stressed that recent disclosure by drugs multinational AstraZeneca in a London court that the Covishield vaccine can cause blood clots in “very rare cases” is not something that was previously ...
LONDON — Europe's medicines regulator found a possible link between the coronavirus vaccine developed by AstraZeneca and the University of Oxford and rare blood clotting issues — though it said the ...
OSLO (Reuters) - Three health workers in Norway who had recently received the AstraZeneca COVID-19 vaccine are being treated in hospital for bleeding, blood clots and a low count of blood platelets, ...
After an all-day meeting that ran beyond its scheduled end, the safety committee of the European Medicines Agency (EMA) concluded Thursday that the benefits of receiving the AstraZeneca COVID-19 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results